Herishanu Y
26  Ergebnisse:
Personensuche X
?
1

P1086: FAVEZELIMAB (ANTI–LAG-3) AND PEMBROLIZUMAB CO-BLOCKA..:

Gregory, G ; Timmerman, J ; Lavie, D...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9428990/.  , 2022
 
?
 
?
4

Effectiveness of ibrutinib as first-line therapy for chroni..:

Morabito F ; Tripepi G ; Del Poeta G...
info:eu-repo/semantics/altIdentifier/pmid/33878220.  , 2021
 
?
5

Comparison of ibrutinib and idelalisib plus rituximab in re..:

Morabito F ; Tripepi G ; Del Poeta G...
info:eu-repo/semantics/altIdentifier/pmid/33378569.  , 2021
 
?
6

Comparison of ibrutinib and idelalisib plus rituximab in re..:

Morabito F ; Tripepi G ; Del Poeta G...
info:eu-repo/semantics/altIdentifier/pmid/33378569.  , 2021
 
?
7

Lower Patient Anxiety and Unchanged Levels of Adherence to ..:

Sarid N ; Mann S ; Herishanu Y...
https://www.dovepress.com/lower-patient-anxiety-and-unchanged-levels-of-adherence-to-hemato-onco-peer-reviewed-fulltext-article-PPA.  , 2021
 
?
8

Assessment of the 4-factor score : Retrospective analysis o..:

Morabito F ; Tripepi G ; Del Poeta G...
info:eu-repo/semantics/altIdentifier/pmid/33580969.  , 2021
 
?
9

COVID-19 severity and mortality in patients with CLL: an up..:

Chatzikonstantinou, T ; Kapetanakis, A ; Scarfo, L...
Chatzikonstantinou , T , Kapetanakis , A , Scarfo , L , Karakatsoulis , G , Allsup , D , Cabrero , A A , Andres , M , Antic , D , Baile , M , Baliakas , P , Bron , D , Capasso , A , Chatzileontiadou , S , Cordoba , R , Correa , J G , Cuellar-Garcia , C , De Paoli , L , De Paolis , M R , Del Poeta , G , Demosthenous , C , Dimou , M , Donaldson , D , Doubek , M , Efstathopoulou , M , Eichhorst , B , El-Ashwah , S , Enrico , A , Espinet , B , Farina , L , Ferrari , A , Foglietta , M , Frederiksen , H , Furstenau , M , Garcia-Marco , J A , Garcia-Serra , R , Gentile , M , Gimeno , E , Glenthoj , A , da Silva , M G , Gutwein , O , Hakobyan , Y K , Herishanu , Y , Hernandez-Rivas , J A , Herold , T , Innocenti , I , Itchaki , G , Jaksic , O , Janssens , A , Kalashnikova , O B , Kalicinska , E , van Gelder , M , Stamatopoulos , K & Ghia , P 2021 , ' COVID-19 severity and mortality in patients with CLL: an update of the international ERIC and Campus CLL study ' , Leukemia , vo....  , 2021
 
?
10

Assessment of the 4-factor score: Retrospective analysis of..:

Morabito F ; Tripepi G ; Del Poeta G...
info:eu-repo/semantics/altIdentifier/pmid/33580969.  , 2021
 
?
11

Assessment of the 4-factor score: Retrospective analysis of..:

Morabito F ; Tripepi G ; Del Poeta G...
info:eu-repo/semantics/altIdentifier/pmid/33580969.  , 2021
 
?
 
?
15

Frontline treatment with the combination obinutuzumab ± chl..:

Herishanu Y ; Shaulov A ; Fineman R...
info:eu-repo/semantics/altIdentifier/pmid/32096887.  , 2020
 
1-15